Moomoo AI 已提取核心信息
On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.
On December 31, 2023, Intelligent Bio Solutions Inc. was the subject of a Schedule 13G filing with the SEC, indicating changes in ownership by several related entities and individuals. Bigger Capital Fund, LP, along with its general partner Bigger Capital Fund GP, LLC, and several associated entities including District 2 Capital Fund LP, District 2 Capital LP, District 2 GP LLC, District 2 Holdings LLC, and individual Michael Bigger, reported ownership of warrants to purchase shares of Intelligent Bio Solutions. The warrants held by each entity and Michael Bigger individually allow for the purchase of 75,758 shares, except for Michael Bigger who holds warrants for 151,516 shares. Collectively, these holdings represent less than one percent of the company's class of securities for each reporting entity, with Michael Bigger's stake amounting to approximately 1.7%. The filing, dated February 5, 2024, asserts that the securities were not acquired for the purpose of changing or influencing the control of Intelligent Bio Solutions Inc. and were not held in connection with any transaction having that purpose or effect.
2023年12月31日，Intelligent Bio Solutions Inc.成为向美国证券交易委员会提交的附表13G文件的主体，该文件显示多个关联实体和个人的所有权发生了变化。Bigger Capital Fund, LP及其普通合伙人Bigger Capital Fund GP, LLC以及包括第二区资本基金有限责任公司、第二区资本有限责任公司、第二区GP LLC、第二区控股有限责任公司和个人迈克尔·比格在内的几家关联实体报告了购买智能生物解决方案股份的认股权证的所有权。每个实体和迈克尔·比格单独持有的认股权证允许购买75,758股股票，但迈克尔·比格除外，他持有151,516股认股...展开全部
2023年12月31日，Intelligent Bio Solutions Inc.成为向美国证券交易委员会提交的附表13G文件的主体，该文件显示多个关联实体和个人的所有权发生了变化。Bigger Capital Fund, LP及其普通合伙人Bigger Capital Fund GP, LLC以及包括第二区资本基金有限责任公司、第二区资本有限责任公司、第二区GP LLC、第二区控股有限责任公司和个人迈克尔·比格在内的几家关联实体报告了购买智能生物解决方案股份的认股权证的所有权。每个实体和迈克尔·比格单独持有的认股权证允许购买75,758股股票，但迈克尔·比格除外，他持有151,516股认股权证。总的来说，这些持股量占公司每个申报实体证券类别的不到百分之一，迈克尔·比格的股份约为1.7％。这份日期为2024年2月5日的文件称，收购这些证券不是为了改变或影响Intelligent Bio Solutions Inc.的控制权，也不是与任何具有该目的或效果的交易有关而持有的。
有用
没用